ReviewImmunity, inflammation and disease2026
Trends and Research Hotspots in Biomarkers of Sjögren's Syndrome Over the Past Two Decades: A Data-Driven Atlas Analysis.
Review in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genistein in autoimmune diseases: from experimental evidence to emerging clinical data.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSjögren's syndrome (SS) is a chronic, systemic inflammatory disorder primarily characterized by dry eyes and dry mouth, often involving multiple organ systems. The disease's heterogeneous clinical presentation and the absence of non-invasive, specific biomarkers complicate its diagnosis and prognostic assessment.
methodsLiterature was sourced from the Web of Science Core Collection, and a bibliometric network was constructed using VOSviewer, CiteSpace, and Bibliometrix. This analysis covered countries/regions, institutions, journals, authors, citations, and keywords, offering an overview of SS biomarker research and identifying future directions.
resultsA total of 1118 articles on SS biomarkers were analyzed. Publication trends fluctuated over the years, with China and the United States leading in volume and citation frequency. The Assistance Publique-Hôpitaux de Paris was the most prolific institution. Among researchers, Xavier Mariette dominated the field, with leading positions in volume of publications, h-index, and total citations. Annals of the Rheumatic Diseases emerged as the most influential journal. Over the past two decades, research has expanded significantly, with emerging themes including "DNA methylation," "genes," "interstitial lung disease," and "data-driven," indicating future focus areas such as epigenetics, severe complication biomarkers, and multi-omics studies.
conclusionThis bibliometric analysis provides a comprehensive view of SS biomarker research, highlighting recent trends and future research directions, offering valuable insights for ongoing studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.